Diversified entity on Thursday confirmed that it’s growing a nasal spray for COVID-19 prevention for which it has initiated medical trials. Developed by scientists at ITC Life Sciences and Expertise Centre (LSTC), Bengaluru, the corporate plans to market the nasal spray underneath the Savlon model as soon as it will get all of the requisite regulatory approvals, in keeping with sources.
When contacted for feedback, a spokesperson of ITC stated, “We’re unable to share extra particulars on the present second because the medical trials are underway.”
Subscribe Gain access to all our Premium contents.
More than 100+ articles.
Buy Article Unlock this article and gain permanent access to read it.
Get real time update about this post categories directly on your device, subscribe now.